Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter | FDA
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules, USP 0.5 mg Due to Dissolution Test Failure | FDA
Teva Recalls Blood Pressure Medication in the U.S.; Adds to Growing List | dLife
Teva Pharmaceuticals announces recall of two blood pressure drugs.
FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes
Metformin recall by FDA: What's the latest news on metformin ER?
Teva Recalls U.S.-Made Drugs Following Contamination Fears | 2021-10-04 | SupplyChainBrain
FDA found big problems a year ago at Chinese plant now recalling tainted valsartan | Fierce Pharma
RECALL ALERT: FDA Adds to List of Recalled Blood Pressure Drugs - The Diabetes Site News
Teva recalls US-made drugs following contamination fears - The Boston Globe
Report: Two more blood pressure drugs recalled for potential cancer risk
Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply | Fierce Pharma
Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate Matter | FDA
Teva recalls 2 lots of hypertension drug on dissolution issues
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
FDA recalls blood pressure medicine due to potential cancer risk
Government of the Virgin Islands - High Blood Pressure Treatment Drug Valsartan Recalled Healthcare professionals and patients are being advised of a voluntary recall of products containing the active pharmaceutical ingredient (API)
Teva Recalls One Lot Of IDArubicin Hydrochloride Injection
FDA Recall Watch | McIntyre Law PC
Dissolution Test Failure Prompts Recall of Anagrelide Capsules - MPR
Teva Pharma Recalls One Lot Of Anagrelide Capsules
Teva's recall of U.S.-made drugs latest example of contamination fears in generic marketplace; report says Lilly, Pfizer and former Mylan plant in Morgantown have been cited in the past | WV News
Teva's Huntington drug launch on hold after FDA rejection | Fierce Biotech
